Michael McKenna, M.D.

Director, Division of Otology and Neurotology

Professor of Otolaryngology, Harvard Medical School


Otology and Neurotology

Board Certification

  • Otolaryngology-Head and Neck Surgery
  • Neurotology

Main Campus
243 Charles Street
Boston, MA 02114
Phone: 617-573-3672
Mon.and Wed. 8 a.m. - 5 p.m.



Clinical Interests

Otology, Neurotology

Research Interests

Otosclerosis and inner ear drug delivery

Select Publications

Kinetics of reciprocating drug delivery to the inner ear. J Control Release. Pararas EE, Chen Z, Fiering J, Mescher MJ, Kim ES, McKenna MJ, Kujawa SG, Borenstein JT, Sewell WF. 2011 Jun 10;152(2):270-7. Epub 2011 Mar 6.

Superior canal dehiscence syndrome associated with the superior petrosal sinus in pediatric and adult patients. McCall AA, McKenna MJ, Merchant SN, Curtin HD, Lee DJ. Otol Neurotol. 2011 Oct;32(8):1312-9.

Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Plotkin SR, Merker VL, Halpin C, Jennings D, McKenna MJ, Harris GJ, Barker FG 2nd. Otol Neurotol. 2012 Aug;33(6):1046-52.

Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis. Quesnel AM, Seton M, Merchant SN, Halpin C, McKenna MJ. OtolNeurotol. 2012 Oct;33(8):1308-14.

Correlation of computed tomography with histopathology in otosclerosis. Quesnel AM, Moonis G, Appel J, O'Malley JT, McKenna MJ, Curtin HD, Merchant SN. Otol Neurotol. 2013 Jan;34(1):22-8. doi: 10.1097/MAO.0b013e318277a1f7. PubMed PMID: 23235550; PubMed Central PMCID: PMC3523308.

View a complete list of publications on pubmed.gov>>



  • University of Southern California School of Medicine, M.D.


  • University of Southern California (General Surgery)


  • Harvard Medical School (Otolaryngology)


  • House Ear Institute (Neurotology and Skull Base Surgery)